These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21516670)

  • 1. [Heart failure and mortality: polyunsaturated fatty acids and the relevance of evidence].
    Bausano G
    Recenti Prog Med; 2011 Jan; 102(1):33-42. PubMed ID: 21516670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
    Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
    Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L;
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
    Finzi AA; Latini R; Barlera S; Rossi MG; Ruggeri A; Mezzani A; Favero C; Franzosi MG; Serra D; Lucci D; Bianchini F; Bernasconi R; Maggioni AP; Nicolosi G; Porcu M; Tognoni G; Tavazzi L; Marchioli R
    Am Heart J; 2011 Feb; 161(2):338-343.e1. PubMed ID: 21315217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 PUFAs and cardiovascular disease prevention.
    Manerba A; Vizzardi E; Metra M; Dei Cas L
    Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective.
    Di Minno MN; Tremoli E; Tufano A; Russolillo A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 Oct; 104(4):664-80. PubMed ID: 20806105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease.
    Brouwer IA; Geelen A; Katan MB
    Prog Lipid Res; 2006 Jul; 45(4):357-67. PubMed ID: 16678270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
    Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
    Lancet; 2008 Oct; 372(9645):1223-30. PubMed ID: 18757090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
    Aleksova A; Masson S; Maggioni AP; Lucci D; Fabbri G; Beretta L; Mos L; Paino AM; Nicolosi GL; Marchioli R; Tognoni G; Tavazzi L; Sinagra G; Latini R;
    Eur J Heart Fail; 2013 Nov; 15(11):1289-95. PubMed ID: 23839902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH;
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):780-6. PubMed ID: 17699287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellners Y
    Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
    Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
    Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsatured fatty acids role in postmyocardial infarction therapy.
    Imazio M; Forno D; Quaglia C; Trinchero R
    Panminerva Med; 2003 Jun; 45(2):99-107. PubMed ID: 12855934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.